DIA 48th Annual Meeting
Click here to go to the previous page
Collaborative Partnerships in Drug Development: An Executive Roundtable Discussion
Track
:
Track 03: Innovative Partnering Models and Outsourcing Strategies
Program Code:
245
Date:
Tuesday, June 26, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
Ed Silverman, UBM, United States
PRESENTER
(S):
Douglas Peddicord, Association of Clinical Research Organizations, United States William Sharbaugh, PPD, United States
Josef von Rickenbach, PAREXEL International, United States
Paula Stafford, Quintiles, United States John Watson, Covance Inc., United States
Jeffrey McMullen, PharmaNet/i3, an inVentiv Health Company, United States
Description
Hear from top executives as they share their vision for the future of pharmaceutical development. What will it look like in five years, and how do we get there? What trends do we see? Have we seen the end of risk- and equity-sharing models in partnering? What are the pressures of private versus public ownership?
The panelists will answer questions and make comments on various facets of the industry in this moderator-led roundtable discussion. DIA will collect questions that are submitted in advance to share with the panel. Submit your question to annualmeetingprogram@diahome.org, Subject: Collaborative Partnerships.
Learning Objectives:
Describe the trends that are being seen in pharmaceutical development
Discuss the pressures associated with private versus public ownership.
The panelists will answer questions and make comments on various facets of the industry in this moderator-led roundtable discussion. DIA will collect questions that are submitted in advance to share with the panel. Submit your question to annualmeetingprogram@diahome.org, Subject: Collaborative Partnerships.
Learning Objectives:
Describe the trends that are being seen in pharmaceutical development
Discuss the pressures associated with private versus public ownership.
This session is a part of:
Handout Online
